Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 15, 2014 06:15 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals Provides Update on FDA Discussions Surrounding Development of Aversion Hydrocodone With Acetaminophen Tablet

PALATINE, IL--(Marketwired - Aug 15, 2014) - Acura Pharmaceuticals Inc. (NASDAQ: ACUR), announced today preliminary discussions from a meeting held with the U.S. Food and Drug Administration (FDA)...
August 04, 2014 16:05 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals Announces Second Quarter 2014 Financial Results

PALATINE, IL--(Marketwired - Aug 4, 2014) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company developing products intended to address medication abuse and misuse,...
July 24, 2014 16:05 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals to Host Second Quarter 2014 Financial Results Conference Call on August 5, 2014

PALATINE, IL--(Marketwired - Jul 24, 2014) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that the Company plans...
May 27, 2014 17:00 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals Provides Update on Its Abuse Deterrent Hydrocodone/Acetaminophen Combination Drug

PALATINE, IL--(Marketwired - May 27, 2014) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR) today announced the US Food and Drug Administration (FDA) advised the Company that the data from our...
May 21, 2014 16:15 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals Announces Settlement of Patent Litigation With Sandoz Inc.

PALATINE, IL--(Marketwired - May 21, 2014) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company developing products intended to address medication abuse and misuse,...
May 08, 2014 06:30 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals Announces Settlement of Patent Litigation With Ranbaxy Inc.

PALATINE, IL--(Marketwired - May 8, 2014) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company developing products intended to address medication abuse and misuse,...
May 05, 2014 16:10 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals Announces First Quarter 2014 Financial Results

PALATINE, IL--(Marketwired - May 5, 2014) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company developing products intended to address medication abuse and misuse,...
April 28, 2014 15:40 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals to Host First Quarter 2014 Financial Results Conference Call on May 6, 2014

PALATINE, IL--(Marketwired - Apr 28, 2014) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that the Company plans...
April 10, 2014 06:15 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals Announces Return of Product Rights

PALATINE, IL--(Marketwired - Apr 10, 2014) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company developing products intended to address medication abuse and misuse,...
March 05, 2014 14:00 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals to Present at the 26th Annual ROTH Conference

PALATINE, IL--(Marketwired - Mar 5, 2014) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company developing products intended to address medication abuse and misuse,...